Mycophenolate Tablets | Mycofit & Mycofit-S - INTAS

Reliable Immunosuppressive & Post-Transplant Care

When managing crucial post-transplant health and vital immunosuppressive therapies, specialists and patients require medications that deliver exact, unwavering results. The Mycophenolate Tablets (available under the trusted Mycofit and Mycofit-S lines) provide a highly effective solution designed to support long-term organ acceptance and overall immunological health. Manufactured by INTAS Pharmaceuticals, a globally respected name in medical manufacturing, these tablets offer the steady clinical performance necessary for individuals dedicated to safeguarding their long-term well-being.

Why Choose Mycofit for Clinical Management?

Navigating immunosuppression requires strict protocol adherence. Instead of dealing with fluctuating absorption rates or severe stomach discomfort, patients benefit from INTAS’s meticulously formulated tablets, which include both standard and delayed-release profiles to suit specific gastrointestinal needs. INTAS provides the built-in trust and rigorous quality control that nephrologists, transplant centers, and leading pharmacies demand when stocking life-saving specialty medications.

Key Product Specifications & Clinical Benefits

Targeted Active Ingredients: Features premium-grade formulations, including Mycophenolate Mofetil IP (Mycofit 500) and Mycophenolic Acid Delayed-Release USP (Mycofit-S 180 and 360), allowing physicians to highly tailor immunosuppressive regimens.

Comprehensive Dosing Options: Available in three precise strengths—180 mg (Mycofit-S), 360 mg (Mycofit-S), and 500 mg (Mycofit)—equipping healthcare providers to titrate medication effectively according to individual patient tolerances and blood panels.

GI-Friendly Options: The 'S' variants feature an advanced delayed-release coating specifically engineered to release the active ingredient in the small intestine, significantly improving gastrointestinal tolerability for sensitive patients.

Optimized Packaging: Conveniently packaged in blister configurations, ensuring individual doses remain hygienic and protected from environmental degradation until the moment of administration.

Essential Storage & Usage Guidelines

Protecting the integrity of this medication is vital for its clinical efficacy. Store the tablets at room temperature (not exceeding 30°C) and protect them strictly from light and moisture. Swallow the delayed-release tablets whole; do not crush, chew, or cut them.

Important Notice: Mycofit and Mycofit-S are prescription-only medications. They must be prescribed, titrated, and strictly monitored by a Registered Medical Practitioner, typically a transplant specialist. Keep securely out of the reach of children.